Ski acts as therapeutic target of Qingyihuaji formula in the treatment of SW1990 pancreatic cancer

Integrative Cancer Therapies

Volumn 9, Issue 1, 2010, Pages 50-58

  Wang, Peng ^a   Chen, Zhen ^a   Meng, Zhi Qiang ^a   Luo, Jian Min ^a   Lin, Jun Hua ^a   Zhou, Zhen Hua ^a   Chen, Hao ^a   Wang, Kun ^a   Shen, Ye Hua ^a   Liu, Lu Ming ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Pancreatic cancer; Qingyihuaji formula (QYHJ); RNA interference; Ski

Indexed keywords

ANTINEOPLASTIC AGENT; MESSENGER RNA; PROTEIN; PROTEIN SKI; QINGYIHUAJI; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VIRUS VECTOR; DNA BINDING PROTEIN; HERBACEOUS AGENT; ONCOPROTEIN; SKI PROTEIN, HUMAN;

AKEBIA; AMORPHOPHALLUS KONJAC; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CHINA; COIX SEED; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOWN REGULATION; DRUG FORMULATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; GYNOSTEMMA; HEDYOTIDIS HERBA; HERBA SCUTELLERIAE BARBATAE; HERBAL MEDICINE; HUMAN; HUMAN CELL; IN VITRO STUDY; LENTIVIRINAE; MEDICINAL PLANT; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR VOLUME; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CARCINOMA; CELL CULTURE; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA; CELL LINE, TUMOR; CELLS, CULTURED; DNA-BINDING PROTEINS; DRUG DELIVERY SYSTEMS; DRUGS, CHINESE HERBAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77953949980     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735409359179     Document Type: Article

References (18)

1. Liu L., Wu L., Lin S., et al. Therapeutic evaluation on advanced pancreatic cancer treated by integrative Chinese and western medicine: clinical analysis of 56 cases. Chin J Integr Med. 2004 ; 10: 236-237.
2. Shen Y., Liu L., Chen Z., et al. Study on Chinese medicine combined with chemotherapy for treatment of 32 cases of advanced pancreatic cancer. Tradit Chin Med. 2006 ; 47: 115-117.
3. Shen Y., Liu L., Shen J., et al. Impact of Qingyihuaji formula on proliferation and cell cycle of experimental pancreatic cancer in vivo. Chin J Basic Med Tradit Chin Med. 2006 ; 12: 97-99.
4. Shen Y., Liu L., Lu Y., et al. Impact of Qingyixiaoji decoction on gene expression of experimental pancreatic cancer in vivo. Zhonghua Zhong Liu Za Zhi. 2005 ; 15: 454-457, 461.
5. Akiyoshi S., Inoue H., Hanai J., et al. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J Biol Chem. 1999 ; 274: 35269-35277.
6. Luo K., Stroschein SL, Wang W., et al. The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev. 1999 ; 13: 2196-2206.
7. Sun Y., Liu X., Eaton EN, et al. Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling. Mol Cell. 1999 ; 4: 499-509.
8. Xu W., Angelis K., Danielpour D., et al. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. Proc Natl Acad Sci U S A. 2000 ; 97: 5924-5929.
9. Reed JA, Bales E., Xu W., et al. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling. Cancer Res. 2001 ; 61: 8074-8078.
10. Fukuchi M., Nakajima M., Fukai Y., et al. Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma. Int J Cancer. 2004 ; 108: 818-824.
11. Buess M., Terracciano L., Reuter J., et al. Amplification of Ski is a prognostic marker in early colorectal cancer. Neoplasia. 2004 ; 6: 207-212.
12. Heider TR, Lyman S., Schoonhoven R., et al. Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer. Ann Surg. 2007 ; 246: 61-68.
13. Ritter M., Kattmann D., Teichler S., et al. Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia. Leukemia. 2006 ; 20: 437-443.
14. Mamidipudi V., Zhang J., Lee KC, et al. RACK1 regulates G1/S progression by suppressing Src kinase activity. Mol Cell Biol. 2004 ; 24: 6788-6798.
15. Lu XG, Zhan LB, Feng BA, et al. Inhibition of growth and metastasis of human gastric cancer implanted in nude mice by d-limonene. World J Gastroenterol. 2004 ; 10: 2140-2144.
16. Shao ZM, Nguyen M., Alpaugh ML, et al. The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. Exp Cell Res. 1998 ; 241: 394-403.
17. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin. 2008 ; 58: 71-96.
18. Liu E., Xiang Y., Jin F., et al. Cancer incidence trends in urban Shanghai,1972-1999. Tumor. 2004 ; 24: 11-15.